A carregar...
Lumiflavin increases the sensitivity of ovarian cancer stem‐like cells to cisplatin by interfering with riboflavin
Here, we used lumiflavin, an inhibitor of riboflavin, as a new potential therapeutic chemosensitizer to ovarian cancer stem‐like cells (CSCs). This study demonstrates that the enrichment of riboflavin in CSCs is an important cause of its resistance to chemotherapy. Lumiflavin can effectively reduce...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652702/ https://ncbi.nlm.nih.gov/pubmed/31187586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14409 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|